Results 101 to 110 of about 14,081 (169)

Progression-free survival exceeding four years after transarterial embolization for liver metastases from triple-negative breast cancer: a case report

Frontiers in Oncology
Liver metastasis in triple-negative breast cancer (TNBC) is associated with an unfavorable prognosis. Prior studies have reported a median overall survival of approximately 3–15 months after the diagnosis of liver metastasis, with a 5-year survival rate ...
Shengjie Liu, Mirinisa Kaicaier, Aisaide Aikelaimu, Yuhan Zhang, Xueping Hou, Yuying Wang, Liyuan Ma, Weihua Jiang   +7 more
doaj   +1 more source

Metastasis-directed radiotherapy for oligometastatic cervical carcinoma: Identifying potential beneficiaries

Background: The role of metastasis-directed radiotherapy (MDRT) in oligometastatic cervical carcinoma (OCC) remains unclear. This study evaluated clinical outcomes of MDRT in patients with OCC and identified prognostic factors associated with survival ...
Lee, Won Hee, Kim, Yong Bae, Wee, Chan Woo, Sangjoon Park, Chan Woo Wee, Won Hee Lee, Yong Bae Kim, Park, Sangjoon   +7 more
core   +1 more source

The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration. [PDF]

Front Oncol
Zhang J, Shi S, Wu J, Tan Z, Liu F, Fang F, Zhen P.   +6 more
europepmc   +1 more source

Novel strategies in radiation therapy: high-dose radiotherapy for oligometastatic/oligo-progressive thymic tumors. [PDF]

Mediastinum
Alaverdashvili T, Rimner A.
europepmc   +1 more source

Oligometastatic GIST: Impact of Treatment Modalities and Metastatic Distribution on Overall Survival. [PDF]

Cancers (Basel)
Pearce WH, Sharma N, Simonelli L, Messina MM, Hill T, Chang YC, Saleh M, Jonczak E, Rosenberg AE, Merchant N, Livingstone AS, Franceschi D, Hester CA, Grossman J, Alessandrino F, Sylvester Comprehensive Cancer Center Bone and Soft Tissue Sarcomas Team.   +15 more
europepmc   +1 more source

Surviving Cancer, Lacking Support: The Hidden Burden of Modern Radiation Oncology in the Treatment of Oligometastatic Disease. [PDF]

Cancers (Basel)
Chasty B, Rembielak A, Berman R, Oldenburger E.   +3 more
europepmc   +1 more source

Efficacy and Safety of Moderate-Dose Stereotactic Body Radiation Therapy (SBRT) for Patients with Oligometastatic Lung Cancer Unfit for Standard SBRT: A Preliminary Single-Center Study. [PDF]

J Clin Med
Park J, Bae BK, Kang MK, Park J.
europepmc   +1 more source

Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience. [PDF]

Clin Transl Radiat Oncol
Tilki B, Guler OC, Demirhan B, Hurmuz P, Elmalı A, Kumru T, Ozyigit G, Yavuz M, Onal C.   +8 more
europepmc   +1 more source

Oligometastatic neuroendocrine tumors: characteristics and prognosis. [PDF]

Br J Cancer
Melhorn P, Postmann J, Raderer M, Kiesewetter B.   +3 more
europepmc   +1 more source

Non-anatomical liver resection using Kelly clamp-crush technique during interval cytoreduction. [PDF]

J Turk Ger Gynecol Assoc
Heda A, Rajaram S, Rakesh NR, Chowdhury N.   +3 more
europepmc   +1 more source